by cardiocomm | Jul 11, 2014 | Press Release
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), announced today it had closed the second tranche of its previously announced private placement equity financing. Under the closing...
by cardiocomm | Jul 6, 2014 | Press Release
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it intends to issue up to...
by cardiocomm | Jun 16, 2014 | Press Release
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that its binding letter of intent with Vigilance, Inc., which was previously announced by the Company on June 16,...
by cardiocomm | Jun 6, 2014 | Press Release
Joint Venture will provide CardioComm Solutions with an equity position in Vigilance and recurrent licensing revenues TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global...
by cardiocomm | May 31, 2014 | Press Release
Company Remains on Track to Complete $1 Million in Financing in Q1 2014 TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)announced today it has closed the second tranche of its...
by cardiocomm | May 28, 2014 | Press Release
HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global...